I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedot..:
Camidge, D. Ross
;
Morgensztern, Daniel
;
Heist, Rebecca S.
...
Clinical Cancer Research. 27 (2021) 21 - p. 5781-5792 , 2021
Link:
https://doi.org/10.1158/1078-0432.ccr-21-0765
RT Journal T1
Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody–Drug Conjugate Targeting c-Met, Monotherapy in Patients with Advanced Non–Small Cell Lung Carcinoma
UL https://suche.suub.uni-bremen.de/peid=cr-10.1158_1078-0432.ccr-21-0765&Exemplar=1&LAN=DE A1 Camidge, D. Ross A1 Morgensztern, Daniel A1 Heist, Rebecca S. A1 Barve, Minal A1 Vokes, Everett A1 Goldman, Jonathan W. A1 Hong, David S. A1 Bauer, Todd M. A1 Strickler, John H. A1 Angevin, Eric A1 Motwani, Monica A1 Parikh, Apurvasena A1 Sun, Zhaowen A1 Bach, Bruce Allen A1 Wu, Jun A1 Komarnitsky, Philip B. A1 Kelly, Karen PB American Association for Cancer Research (AACR) YR 2021 SN 1078-0432 SN 1557-3265 JF Clinical Cancer Research VO 27 IS 21 SP 5781 OP 5792 LK http://dx.doi.org/https://doi.org/10.1158/1078-0432.ccr-21-0765 DO https://doi.org/10.1158/1078-0432.ccr-21-0765 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)